March 9, 2018

No Image

The Week in Movie News: Oscar Winners, SXSW Buzz, the Live-Action 'Star Wars' Series and More

Need a quick recap on the past week in movie news? Here are the highlights:

BIG NEWS

The Shape of Water is the Best Picture of 2017: The 90th Academy Awards were held Sunday night with Oscars going to a wide spread of nominees. But the big winner was Guillermo del Toro and The Shape of Water, which won Best Picture and Best Director. See the full list of winners here and see our highlights of the ceremony here and red carpet favorites here.

GREAT NEWS

Jon Favreau will steer the Star Wars series: Lucasfilm announced Iron Man and The Jungle Book director Jon Favreau as the writer and producer of the first live-action Star Wars TV series, which will be found on Disney’s new streaming service. Read more here.

SURPRISING NEWS

Steven Spielberg is passing Robopocalypse to Michael Bay: It’s not surprising that Steven Spielberg would recruit Michael Bay for another collaboration following Transformers, but it is surprising that Spielberg is giving up directing Robopocalypse, which he’s been developing for years. Read more on that and Bay’s next project here.

FESTIVAL BUZZ

SXSW 2018 preview: With the SXSW Film Festival beginning this week, we highlighted all the movies and events that people are already buzzing about. Read the whole guide here.

EXCLUSIVE BUZZ

Marc Forster talks Christopher Robin: We talked to Christopher Robin director Marc Forster ahead of the movie’s teaser debut, and he explained what we can expect from Disney’s live-action take on the Winnie the Pooh characters. Read the whole interview here.

COOL CULTURE

An Unused Oscars Musical Number: The Lonely Island came up with a song to perform at the Oscars last weekend, but the Academy declined to use it. Watch the silly musical number, which involves Thor and Wonder Woman, below.

[embedded content]

MUST-WATCH TRAILERS

Mary Poppins Returns welcomes back an icon: Disney dropped the first teaser trailer for Mary Poppins Returns during the Oscars, and it’s supercalifragilisticexpialidocious. Watch it below.

[embedded content]

Christopher Robin tugs at our heartstrings: Disney also debuted the first teaser for Christopher Robin, which spotlights Ewan McGregor as the now-grown title character and teases a live-action Winnie the Pooh. Watch it here:

[embedded content]

The Seagull lets Saoirse Ronan soar: Saoirse Ronan follows her Oscar-nominated performance in Lady Bird with a starring role in the latest adaptation of Anton Chekhov’s The Seagull with Annette Bening and Elisabeth Moss. Watch it below.

[embedded content]

and

Let’s block ads! (Why?)


No Image

No Go For Idaho: State Will Have To Rethink Its 'Freedom' Health Policies

Idaho Gov. C.L. “Butch” Otter says Thursday’s letter from the Trump administration “was not a rejection of our approach,” but rather an invitation to keep talking about how to make Idaho’s state-based health plans pass muster.

Otto Kitsinger/AP

hide caption

toggle caption

Otto Kitsinger/AP

No, you can’t.

That’s what federal officials told Idaho regulators and the state’s governor late Thursday regarding the state’s plan to allow insurers to sell health plans that fall short of the Affordable Care Act’s requirements.

But the letter from the Trump administration did offer an alternative: Tweak your plan a bit to make them qualify as “short-term” policies. These alternatives, which offer coverage for a limited time, are exempted from ACA rules — including the rule that bars insurers from rejecting people who have pre-existing medical conditions.

“On the one hand, they’re saying they’re going to enforce the ACA,” says Sarah Lueck, a senior policy analyst at the Center on Budget and Policy Priorities. But, Lueck adds, the Health and Human Services Department also seems to say, ” ‘if you want to roll back protections for people with pre-existing conditions, we have some ideas for you.’ And that concerns me.”

Idaho’s approach, announced in January, would have allowed insurers to offer “state-based” insurance plans that did not include some of the ACA’s consumer protections. A few weeks later, Idaho Blue Cross jumped in with five “Freedom Blue” state-based plans it hoped to sell.

Regulators in other states were watching the Idaho situation. Its move was viewed either as a brazen effort to flout federal law or an innovative attempt to stabilize the market. Regardless, Idaho’s action meant the Trump administration had to take a position: Enforce the ACA or look away.

Here are four key takeaways from the administration’s response to Idaho, and how the ruling may play elsewhere.

States and insurance carriers can’t ignore federal law

Although Thursday’s letter from Seema Verma, head of the federal Centers for Medicare & Medicaid Services, commended Idaho’s effort to “address the damage” caused by the ACA, it said that, as proposed, the state-based plans would violate at least eight of the federal health law’s provisions. For example, the ACA forbids insurers from charging sick people more for a policy than it charges those who are considered healthy; it bans the establishment of annual or lifetime coverage caps; and it won’t allow insurers to reject applicants who have pre-existing conditions.

Verma’s letter noted that if plans that don’t meet ACA standards were sold in Idaho, insurance carriers might face significant financial penalties. Health policy specialists say they would be surprised if insurers would want to take that risk.

“It’s one thing for the state to take on the CMS, but quite another for carriers,” says Jan Dubauskas, general counsel for the IHC Group, which sells short-term health insurance nationally. “When I heard that, I thought, ‘This is the end for state-based plans.’ “

But Idaho Gov. Butch Otter, a Republican, has been upbeat, saying the letter from Verma “was not a rejection of our approach,” but “an invitation … to continue discussing … what can and cannot be included in state-based plans.”

Late Friday, Idaho Blue Cross issued a statement expressing disappointment in the CMS decision, but also echoing Otter’s willingness to move forward.

The timetable going forward is not immediately clear, although both federal regulators and state officials say they are willing to talk about alternatives to Idaho’s original proposal. Following Verma’s suggestion to get new short-term plans on the market would also require Idaho’s insurers to consider their options, modify the plans and come up with new premium rates — all of which takes time.

Short-term plans get another boost

Dubauskas and others say the Idaho decision could increase interest in short-term plans.

Such policies have been sold for years, meant as a stopgap for people between jobs. They are less expensive than ACA plans, mainly because they are allowed to reject people who have health conditions (or exclude coverage for such conditions) and have other limitations.

Most short-term plans don’t cover treatment for substance abuse or mental health issues; few cover maternity care and some don’t include prescription drug coverage. They generally can’t be renewed — meaning consumers must reapply and answer medical questions each time their policies expire.

The Obama administration, fearing that short-term plans would suck relatively healthy people out of the ACA market, limited such policies to 90-day terms. The Trump administration, however, has proposed allowing short-term plans to last for up to a year. These final rules aren’t expected for at least another two months.

Ironically, Idaho Insurance Director Dean Cameron had in January promoted the more robust “state-based” plans — like those the Blues insurer wanted to sell in Idaho— as an alternative to short-term coverage.

After getting the CMS letter, Cameron told the Idaho Statesman newspaper that short-term plans might be easier for the Trump administration to handle legally, but could cause consumers more problems than what Idaho had proposed.

Critics fear that consumers will buy such plans without understanding their limitations.

“They might think it’s health insurance like they’re used to,” Lueck says. “But it’s really not. It’s really very bare-bones.”

State reactions will vary widely, creating different rules around the country

Even if the Trump administration’s proposal to extend short-term coverage to a full year is finalized, states can set stricter rules.

A handful of states already do.

New York and New Jersey require many of the same rules as the ACA for policies sold in their states. But insurers won’t sell short-term plans there.

Four states — Arizona, Michigan, Minnesota and Oregon — limit the length of short-term plans sold in their states to 185 days, according to a survey by the Commonwealth Fund and researchers at Georgetown University.

“A small group of largely blue states have some regulation [of short-term plans], but not very many,” says Sabrina Corlette, a research professor at Georgetown University’s Health Policy Institute. “It’s possible that if this rule is finalized we will see more states start to step up and regulate short-term markets.”

Conversely, lawmakers in other states may promote short-term coverage as a lower-cost alternative to the ACA — although people with pre-existing conditions may not be able to buy such plans.

“Politically, short-term plans have some appeal because lawmakers can say now there’s a cheaper option out there,” Corlette notes.

The increased emphasis on short-term plans could increase premiums

Actuaries fear that short-term plans — or state-based plans like those rejected in Idaho — would drive up costs for people who remain in more comprehensive ACA coverage.

That’s because younger and healthier people might be tempted to drop their ACA coverage, leaving only those who are older, sicker and costlier in the remaining pool. That, in turn, drives up premiums — affecting millions of Americans who don’t receive subsidies and already struggle to pay for their health insurance.

But just how many people would jump to new, short-term coverage?

The Trump administration has estimated that about 100,000 to 200,000 people with existing ACA coverage would make the shift, while other specialists in health insurance suggest higher numbers.

Christopher Condeluci, a Washington, D.C., attorney who specializes in employee benefits and previously served as the tax and benefits counsel to the U.S. Senate Finance Committee, says it’s unclear which estimates are correct.

The real issue to keep in mind, Condeluci says, is that an increasing number of people who don’t get subsidies are already choosing to either forgo coverage or pick an alternative, such as a short-term plan.

“People are voting with their feet,” he said. “That cannot be overlooked.”

Kaiser Health News is a nonprofit news service covering health issues. It is an editorially independent program of the Kaiser Family Foundation that is not affiliated with Kaiser Permanente. You can follow KHN senior correspondent Julie Appleby on Twitter @Julie_Appleby.

Let’s block ads! (Why?)


No Image

Martin Shkreli Sentenced to 7 Years For Securities Fraud

Former pharmaceutical CEO Martin Shkreli (left) was sentenced to seven years for securities fraud on Friday.

Elizabeth Williams/AP

hide caption

toggle caption

Elizabeth Williams/AP

Martin Shkreli, the former pharmaceutical executive who has been publicly excoriated for sharply increasing the price of a lifesaving HIV drug and derisively referred to as the “Pharma Bro,” was sentenced on Friday to seven years in prison for defrauding investors in two failed hedge funds and a drug company he once ran.

It’s less than half of the 15 years prosecutors were seeking, but it far exceeds the minimum 18-month sentence Shkreli’s attorneys were hoping to secure for their client, whose 35th birthday is later this month.

Shkreli was found guilty on two counts of securities fraud for duping hedge fund investors in MSMB Capital Management and MSMB Healthcare about the financial performance of the two companies that he operated. And he was convicted of conspiracy to commit securities fraud for manipulating stock shares of Retrophin, a pharmaceutical company he created.

U.S. District Judge Kiyo Matsumoto also ruled Monday that Shkreli must forfeit the money he made from his fraud — nearly $7.4 million — and pay a $75,000 fine. And, as NPR’s Colin Dwyer reported, if Shkreli can’t come up with the funds to pay back the government, he’ll have to hand over a few prized possessions, including a one-of-a-kind Wu-Tang Clan album and a Picasso painting.

Shkreli, who has often appeared defiant both in the courtroom and in interviews, made a sob-filled plea for leniency during the 2 1/2-hour proceedings leading up to Matsumoto’s decision, according to CNBC.

” ‘The one person to blame for me being here today is me,’ a choked-up Shkreli told a judge before she imposed the prison term. ‘Not the government. There is no conspiracy to take down Martin Shkreli.’

” ‘I took down Martin Shkreli with my disgraceful and shameful actions.’

” ‘This is my fault. I am no victim here,’ Shkreli said, before breaking down into tears as he promised not to let his lawyer Benjamin Brafman down in his efforts to contribute to society.

” ‘Do not feel bad for me,’ Shkreli told a packed courtroom that included many of his supporters and family members.

“And he had a message for the investors he duped: ‘I am terribly sorry I lost your trust … You deserve far better.’ “

Shkreli emerged as a public villain in 2015 after raising the price of Daraprim by more than 5,000 percent, from $13.50 to $750 per pill as CEO of Turing Pharmaceuticals. A later offer to pay $5,000 for a strand of Hillary Clinton’s hair — follicle included — after his conviction when he was out on bail, did nothing to rehabilitate his image. In fact, Matsumoto sent him back to jail for the stunt that Shkreli later claimed was a joke.

In a letter to the judge dated Feb. 26, Shkreli wrote:

“I feel I should try to explain my personality.

“I am an irreverant and free-wheeling individual, who has never been shy about speaking my mind. I am an individual who prizes equal rights, scholastic achievement and individuality. Please understand that when I get into a public war of words with someone, my comments do not always reflect my true nature. Sadly, when I get dragged into a mud fight, I often dive in, head first.”

Shkreli has been held in a federal prison in Brooklyn, N.Y., for six months. He said being behind bars is “both the most frightening experience of my life but also an opportunity for me to see a side of the world seldom seen or discussed.”

Let’s block ads! (Why?)